KOWALIK; Timothy F.

Patent Applications and Registrations

Patent applications and USPTO patent grants for KOWALIK; Timothy F..The latest application filed is for "therapeutic alteration of transplantable tissues through in situ or ex vivo exposure to rna interference molecules".

Company Profile

5.11.14

KOWALIK; Timothy F. - Princeton MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Therapeutic Alteration Of Transplantable Tissues Through In Situ Or Ex Vivo Exposure To Rna Interference Molecules App 20220119814 - KOWALIK; Timothy F. ; et al.	2022-04-21
Therapeutic alteration of transplantable tissues through in situ or ex vivo exposure to RNA interference molecules Grant 11,220,686 - Kowalik , et al. January 11, 2	2022-01-11
Targeting Cell Tropism Receptors to Inhibit Cytomegalovirus Infection App 20200376077 - Kowalik; Timothy F. ; et al.	2020-12-03
Therapeutic Alteration Of Transplantable Tissues Through In Situ Or Ex Vivo Exposure To Rna Interference Molecules App 20200063129 - KOWALIK; Timothy F. ; et al.	2020-02-27
Therapeutic alteration of transplantable tissues through in situ or ex vivo exposure to RNA interference molecules Grant 10,260,066 - Kowalik , et al.	2019-04-16
Modulation of human cytomegalovirus replication by micro-RNA 132 (miR132), micro-RNA 145 (miR145) and micro-RNA 212 (miR212) Grant 10,227,591 - Kowalik , et al.	2019-03-12
MODULATION OF HUMAN CYTOMEGALOVIRUS REPLICATION BY MICRO-RNA 132 (miR132), MICRO-RNA 145 (miR145) AND MICRO-RNA 212 (miR212) App 20170101640 - Kowalik; Timothy F. ; et al.	2017-04-13
Modulation of human cytomegalovirus replication by micro-RNA 132 (miR132), micro-RNA 145 (miR145) and micro-RNA 212 (miR212) Grant 9,562,232 - Kowalik , et al. February 7, 2	2017-02-07
Therapeutic Alteration Of Transplantable Tissues Through In Situ Or Ex Vivo Exposure To Rna Interference Molecules App 20160024507 - KOWALIK; Timothy F. ; et al.	2016-01-28
Therapeutic alteration of transplantable tissues through in situ or ex vivo exposure to RNA interference molecules Grant 9,150,861 - Kowalik , et al. October 6, 2	2015-10-06
MODULATION OF HUMAN CYTOMEGALOVIRUS REPLICATION BY MICRO-RNA 132 (miR132), MICRO-RNA 145 (miR145) AND MICRO-RNA 212 (miR212) App 20150259689 - Kowalik; Timothy F. ; et al.	2015-09-17
Therapeutic Alteration Of Transplantable Tissues Through In Situ Or Ex Vivo Exposure To Rna Interference Molecules App 20150191731 - KOWALIK; Timothy F. ; et al.	2015-07-09
Therapeutic alteration of transplantable tissues through in situ or ex vivo exposure to RNA interference molecules Grant 8,940,709 - Kowalik , et al. January 27, 2	2015-01-27
Modulation of human cytomegalovirus replication by micro-RNA 132 (miR132), micro-RNA 145 (mi145) and micro-RNA 212 (miR212) Grant 8,933,045 - Kowalik , et al. January 13, 2	2015-01-13
Therapeutic Alteration Of Transplantable Tissues Through In Situ Or Ex Vivo Exposure To Rna Interference Molecules App 20130273142 - KOWALIK; Timothy F. ; et al.	2013-10-17
Therapeutic alteration of transplantable tissues through in situ or ex vivo exposure to RNA interference molecules Grant 8,361,976 - Kowalik , et al. January 29, 2	2013-01-29
MODULATION OF HUMAN CYTOMEGALOVIRUS REPLICATION BY MICRO-RNA 132 (miR132), MICRO-RNA 145 (miR145) AND MICRO-RNA 212 (miR212) App 20120178791 - KOWALIK; Timothy F. ; et al.	2012-07-12
VIRUS-SPECIFIC miRNA SIGNATURES FOR DIAGNOSIS AND THERAPEUTIC TREATMENT OF VIRAL INFECTION App 20110151430 - KOWALIK; Timothy F. ; et al.	2011-06-23
Virally-encoded RNAs as substrates, inhibitors and delivery vehicles for RNAi Grant 7,776,569 - Kowalik , et al. August 17, 2	2010-08-17
Therapeutic alteration of transplantable tissues through in situ or ex vivo exposure to RNA interference molecules App 20060073127 - Kowalik; Timothy F. ; et al.	2006-04-06
Interspersed repetitive element RNAs as substrates, inhibitors and delivery vehicles for RNAi App 20050186589 - Kowalik, Timothy F. ; et al.	2005-08-25
Virally-encoded RNAs as substrates, inhibitors and delivery vehicles for RNAi App 20050171041 - Kowalik, Timothy F. ; et al.	2005-08-04
RNAi targeting of viruses App 20040248839 - Kowalik, Timothy F.	2004-12-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.